Issuance of Stock Acquisition Rights for Directors, Audit & Supervisory Board Members and Employees
First written in FY2018-Q4. 19 of 20 entries say "Advanced", first in FY2019-Q3. Latest entry: FY2026-H1.
- FY2026-H1AdvancedAnnual report
「30,600 91,242,700 12 11,341 12 11,320 (Note) 1. These were issued through the exercise of stock acquisition rights.」
From April to September 2025, 30,600 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2025-H1AdvancedAnnual report
「1 May 2024–30 September 2024 34,700 These were issued through the exercise of stock acquisition rights.」
From May to September 2024, 34,700 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2024-Q3AdvancedAnnual report
「1 October 2023–31 December 2023 31,500 79,215,500 (Note) 1. These were issued through the exercise of stock acquisition rights.」
From October to December 2023, 31,500 shares were issued through the exercise of stock acquisition rights, and the issuance of a further 51,900 shares in January 2024 was also disclosed. - FY2024-Q2AdvancedAnnual report
「1 July 2023–30 September 2023 (Note) 12,800 79,184,000 1 2,376 1 2,355 (Note) These were issued through the exercise of stock acquisition rights.」
From July to September 2023, 12,800 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2024-Q1AdvancedAnnual report
「1 April 2023–30 June 2023 (Note) 59,700 79,171,200 19 2,375 19 2,354 (Note) These were issued through the exercise of stock acquisition rights.」
From April to June 2023, 59,700 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2023-Q3AdvancedAnnual report
「1 October 2022–31 December 2022 (Note) 1 78,400 79,074,100 6 2,351 6 2,329 (Note) 1. These were issued through the exercise of stock acquisition rights.」
From October to December 2022, 78,400 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2023-Q2AdvancedAnnual report
「1 July 2022–30 September 2022 (Note) 27,600 78,995,700 (Note) These were issued through the exercise of stock acquisition rights.」
From July to September 2022, 27,600 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2023-Q1AdvancedAnnual report
「1 April 2022–30 June 2022 (Note) 1 28,800 78,968,100 3 2,342 3 2,321 (Note) 1. These were issued through the exercise of stock acquisition rights.」
During the first quarter, 28,800 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2022AdvancedAnnual report
「8 April 2021–8 March 2022 (Note) 1 848,900 78,939,300 71 2,340 71 2,319」
During the fiscal year, 848,900 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2022-Q3AdvancedAnnual report
「1 October 2021–31 December 2021 (Note) 92,100 78,641,300 13 2,314 13 2,293 (Note) 1. These were issued through the exercise of stock acquisition rights. 2. From 1 January 2022 to 31 January 2022, the total number of issued shares increased by 172,800 through the exercise of stock acquisition rights, while capital and capital reserves each increased by ¥14 million.」
From October to December 2021, 92,100 shares were issued through the exercise of stock acquisition rights, and the issuance of a further 172,800 shares in January 2022 was also disclosed. - FY2022-Q2AdvancedAnnual report
「1 July 2021–30 September 2021 (Note) 1 348,800 78,549,200 23 2,301 23 2,280 (Note) 1. These were issued through the exercise of stock acquisition rights.」
From July to September 2021, 348,800 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2022-Q1AdvancedAnnual report
「1 April 2021–30 June 2021 (Note) 1 110,000 78,200,400 9 2,279 9 2,257 (Note) 1. These were issued through the exercise of stock acquisition rights.」
From April to June 2021, 110,000 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2021-Q3AdvancedAnnual report
「1 October 2020–31 December 2020 (Note) 1 336,400」
From October to December 2020, 336,400 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2021-Q2AdvancedAnnual report
「1 July 2020–30 September 2020 (Note) 1 281,600 77,127,600 19 2,198 19 2,176 (Note) 1. These were issued through the exercise of stock acquisition rights.」
From July to September 2020, 281,600 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2021-Q1AdvancedAnnual report
「1 April 2020–30 June 2020 (Note) 38,400 76,846,000 2 2,178 2 2,156 (Note) These were issued through the exercise of stock acquisition rights.」
From April to June 2020, 38,400 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees continued. - FY2020-Q3AdvancedAnnual report
「1 October 2019–31 December 2019 (Note) 1 384,000」
From October to December 2019, 384,000 shares were issued through the exercise of stock acquisition rights, and the exercise of stock acquisition rights granted to officers and employees progressed. - FY2019AdvancedAnnual report
「The increase in the total number of issued common shares comprised an increase of 1,190,400 shares from the exercise of stock acquisition rights and an increase of 37,145,400 shares from a stock split.」
From October 2018 to March 2019, 1,190,400 shares were issued through the exercise of stock acquisition rights, further advancing capital transactions from the exercise results disclosed previously. - FY2019-Q4AdvancedAnnual report
「Second Series Stock Acquisition Rights with Share-Based Compensation Features Employees: 2 Number of stock acquisition rights (units) * (Note 1) 485 Number of underlying shares (shares) * (Note 1) 48,500 Exercise period for stock acquisition rights * From 18 December 2021 To 17 December 2028」
For the Second Series Stock Acquisition Rights with Share-Based Compensation Features issued on 17 December 2018, 485 rights representing 48,500 shares were granted to 2 employees, with an exercise period from 18 December 2021 to 17 December 2028. - FY2019-Q3AdvancedAnnual report
「1 September 2018–30 November 2018 (Note 2) 552,000 These were issued through the exercise of stock acquisition rights.」
From September to November 2018, 552,000 shares were issued through the exercise of stock acquisition rights, and capital transactions related to previously issued stock acquisition rights progressed. - FY2018-Q4First statedAnnual report
「The stock acquisition rights issued during the third quarter accounting period are as follows.」
Based on the resolution of 27 November 2017, 385 stock acquisition rights, representing 38,500 underlying shares, were issued, with an exercise period from 13 December 2020 to 12 December 2027.